scispace - formally typeset
D

Deborah J. Cook

Researcher at McMaster University

Publications -  942
Citations -  165225

Deborah J. Cook is an academic researcher from McMaster University. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 173, co-authored 907 publications receiving 148928 citations. Previous affiliations of Deborah J. Cook include McMaster University Medical Centre & Queen's University.

Papers
More filters
Journal ArticleDOI

Ventilator associated pneumonia: perspectives on the burden of illness.

TL;DR: VAP is associated with approximately a 4 day increase in length of ICU stay and an attributable mortality of approximately 20–30 %, and Ventilator-associated pneumonia is a major morbid outcome among critically ill patients.
Journal ArticleDOI

Comparison of open and closed questionnaire formats in obtaining demographic information from Canadian general internists.

TL;DR: Investigators can achieve higher response rates for demographic items using closed format response options, but at the risk of increasing inaccuracy in response to questions requiring computation, according to this study.
Journal ArticleDOI

Recovery after critical illness: putting the puzzle together-a consensus of 29.

TL;DR: This review seeks to highlight how critical illness and critical care affect longer-term outcomes, to underline the contribution of ICU delirium to cognitive dysfunction several months after ICU discharge, to give new insights into ICU acquired weakness, and to emphasize the importance of value-based healthcare.
Journal ArticleDOI

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.

TL;DR: Quantification of the determinants of the threshold NNT and of the minimum event rate to justify treatment can assist clinicians and patients in the explicit use of underlying values when making treatment decisions.
Journal ArticleDOI

Single Daily Dosing of Aminoglycosides in Immunocompromised Adults: A Systematic Review

TL;DR: The results suggest that SDD of aminoglycosides may be efficacious for febrile, immunocompromised patients and additional studies are necessary for more precise quantification of the mortality and toxicity risk ratios.